News

BioCity, Alderley Park based Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Research UK Manchester Institute (CRUK MI), has licensed Flare for fresh insights into structure-based drug design. “Putting easy-to use and visually...

Cresset, innovative provider of software and contract research services for small molecule discovery and design, and Elixir Software, provider of real-time workflow tracking applications, have formed an alliance whereby the combination of their technologies will form the basis of a new groundbreaking application, which will radically...

This time last month, the BioCity team were adding the finishing touches to their new green space. BioCity, Nottingham is now home to an award-winning RHS garden, providing an outdoor space for workers based at the site. The garden, ‘Finding [urban] Nature’ (F[u]N), was designed by...

BioCity, Glasgow based Clyde Biosciences, the leader in cardiac cell function assessment, announced that its proprietary CellOPTIQ® High Content Assay (HCA) outperformed other assay types in the global CiPA myocyte study designed to develop more accurate and comprehensive in vitro cardiac safety evaluation of new...

Leading DMPK/ADME provider, XenoGesis has celebrated the official opening of its new laboratories and offices at BioCity Nottingham’s state-of-the-art Discovery Building. Founded in 2011 by Richard Weaver, XenoGesis is an independent laboratory-based contract research organisation specialised in preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis, in...